Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms, Castration-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Phase: Phase 1/2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20191
20201
20212
20221
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK2
Merck Sharp & Dohme LLC2
Arcus Biosciences, Inc.1
Celcuity Inc1
Clarity Pharmaceuticals Ltd1
Novartis Pharmaceuticals1
Nuvation Bio Inc.1
Samsung Medical Center1
T.O.A.D. Oncology SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant11
Prostatic Neoplasms3
Endometrial Neoplasms2
Esophageal Neoplasms2
Mesothelioma, Malignant2
Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.